{"lastClose": 1.159999966621399, "len": 483, "date": "2023-02-16", "alpha_1": -0.9058839927767746, "beta_1": 0.19508743142792692, "drawup_1": 0.7325581218050006, "natr_1": 31.5288233171842, "sup_1": -0.016666640975008695, "res_1": 0.30201150266910637, "bullPattern_1": ["HIKKAKE"], "bearPattern_1": [], "rsi_1": 63.77550561147173, "adx_1": 44.379296136854805, "drawdown_1": -0.9048152301462742, "stratHoldSharpe_1": -1.7594351994201622, "stratHoldAlpha_1": 249.7722851763659, "stratHoldDrawdown_1": -0.8220664724021582, "alpha_3mo": -0.5565026634732884, "beta_3mo": -0.32419321272789814, "drawup_3mo": 0.4117647223819081, "natr_3mo": 31.5288233171842, "sup_3mo": -0.031609166166963916, "res_3mo": 0.1867816419744142, "bullPattern_3mo": ["DOJI", "GRAVESTONEDOJI", "LONGLEGGEDDOJI"], "bearPattern_3mo": ["HARAMI", "HARAMICROSS", "SHORTLINE"], "rsi_3mo": 73.6841999121168, "adx_3mo": 52.361518322434975, "drawdown_3mo": -0.4295301889923263, "stratHoldSharpe_3mo": -0.7557985515869016, "stratHoldAlpha_3mo": 250.54378556886266, "stratHoldDrawdown_3mo": -0.38971582110595937, "Market Cap": 295658587, "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Country": "Cayman Islands", "Sector": "Health Care", "Name": "LumiraDx Limited", "alpha%_1": 0.00407036592673276, "beta%_1": 0.06019475430325862, "drawup%_1": 0.6823759519359989, "natr%_1": 1.0, "drawdown%_1": 0.004121733448713894, "stratHoldSharpe%_1": 0.004733491961176282, "stratHoldAlpha%_1": 5.737266438270982e-07, "stratHoldDrawdown%_1": 0.00435222949513382, "alpha%_3mo": 0.10788892299541991, "beta%_3mo": 0.01150540917300534, "drawup%_3mo": 0.8092859717105592, "natr%_3mo": 1.0, "drawdown%_3mo": 0.00027254260637298765, "stratHoldSharpe%_3mo": 0.13102736891805, "stratHoldAlpha%_3mo": 0.08102365313167509, "stratHoldDrawdown%_3mo": 0.00027248333233778724}